Project P2025-00002 ยท JJJG-DEMO-2025 ยท Pharmacokinetics / LC-MS
Dashboard generated March 15, 2026 ยท Source: Sapio Sciences LIMS
| Subject ID | Group | Subgroup | Sex | Treatment | Dose Level | Status | Study Group Rec | Animal Rec ID | StudySubject Rec ID | Samples |
|---|---|---|---|---|---|---|---|---|---|---|
| 1A00003M | 1 | A | โ M | A | 20 mg/kg IV | Awaiting Assignment | 517764 | 517793 | 517781 | 24 |
| 1A00004M | 1 | A | โ M | A | 20 mg/kg IV | Awaiting Assignment | 517764 | 517794 | 517782 | 9 |
| 1B00002F | 1 | B | โ F | A | 20 mg/kg IV | Awaiting Assignment | 517764 | 517795 | 517783 | 9 |
| 1B00001F | 1 | B | โ F | A | 20 mg/kg IV | Awaiting Assignment | 517764 | 517796 | 517784 | 9 |
| 2A00003M | 2 | A | โ M | B | 10 mg/kg IV | Awaiting Assignment | 517766 | 517797 | 517785 | 24 |
| 2A00001M | 2 | A | โ M | B | 10 mg/kg IV | Awaiting Assignment | 517766 | 517798 | 517786 | 9 |
| 2B00002F | 2 | B | โ F | B | 10 mg/kg IV | Awaiting Assignment | 517766 | 517799 | 517787 | 24 |
| 2B00004F | 2 | B | โ F | B | 10 mg/kg IV | Awaiting Assignment | 517766 | 517800 | 517788 | 9 |
| 3A00003M | 3 | A | โ M | C | Vehicle (Control) | Awaiting Assignment | 517765 | 517801 | 517789 | 9 |
| 3A00004M | 3 | A | โ M | C | Vehicle (Control) | Awaiting Assignment | 517765 | 517802 | 517790 | 24 |
| 3B00002F | 3 | B | โ F | C | Vehicle (Control) | Awaiting Assignment | 517765 | 517803 | 517791 | 9 |
| 3B00001F | 3 | B | โ F | C | Vehicle (Control) | Awaiting Assignment | 517765 | 517804 | 517792 | 24 |
| Subject ID | Group | Treatment | Sex | Sample Count | Distribution |
|---|---|---|---|---|---|
| 1A00003M | 1 | A | M | 24 | |
| 1A00004M | 1 | A | M | 9 | |
| 1B00002F | 1 | A | F | 9 | |
| 1B00001F | 1 | A | F | 9 | |
| 2A00003M | 2 | B | M | 24 | |
| 2A00001M | 2 | B | M | 9 | |
| 2B00002F | 2 | B | F | 24 | |
| 2B00004F | 2 | B | F | 9 | |
| 3A00003M | 3 | C | M | 9 | |
| 3A00004M | 3 | C | M | 24 | |
| 3B00002F | 3 | C | F | 9 | |
| 3B00001F | 3 | C | F | 24 |
| Subject | Group | Treatment | Day 0 โ Expected | Day 0 โ Actual | Day 0 โ Status | Day 1 โ Expected | Day 1 โ Actual | Day 1 โ Status | Day 2 โ Expected | Day 2 โ Actual | Day 2 โ Status |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1A00003M | 1 | A | 20.0 mg/kg | 0.3600 mL | โ Completed | 0.3707 mL | 0.4003 mL | โ Completed | 0.4539 mL | 0.4766 mL | โ Completed |
| 1A00004M | 1 | A | 20.0 mg/kg | 0.3800 mL | โ Completed | 0.3575 mL | 0.3504 mL | โ Completed | 0.4049 mL | 0.4373 mL | โ Completed |
| 1B00002F | 1 | A | 20.0 mg/kg | 0.3880 mL | โ Completed | 0.4107 mL | 0.4271 mL | โ Completed | 0.4616 mL | 0.4846 mL | โ Completed |
| 1B00001F | 1 | A | 20.0 mg/kg | 0.3680 mL | โ Completed | 0.3570 mL | 0.3749 mL | โ Completed | 0.3711 mL | 0.3637 mL | โ Completed |
| 2A00003M | 2 | B | 10.0 mg/kg | 0.1930 mL | โ Completed | 0.2044 mL | 0.2167 mL | โ Completed | 0.2255 mL | 0.2412 mL | โ Completed |
| 2A00001M | 2 | B | 10.0 mg/kg | 0.1890 mL | โ Completed | 0.2064 mL | 0.2002 mL | โ Completed | 0.2270 mL | 0.2224 mL | โ Completed |
| 2B00002F | 2 | B | 10.0 mg/kg | 0.1950 mL | โ Completed | 0.2106 mL | 0.2211 mL | โ Completed | 0.2232 mL | 0.2321 mL | โ Completed |
| 2B00004F | 2 | B | 10.0 mg/kg | 0.1850 mL | โ Completed | 0.2001 mL | 0.2081 mL | โ Completed | 0.2080 mL | 0.2101 mL | โ Completed |
| 3A00003M | 3 | C | Vehicle Control โ No active agent administered | ||||||||
| 3A00004M | 3 | C | Vehicle Control โ No active agent administered | ||||||||
| 3B00002F | 3 | C | Vehicle Control โ No active agent administered | ||||||||
| 3B00001F | 3 | C | Vehicle Control โ No active agent administered | ||||||||
| Subject | Trt | Baseline (D0) | TP 1 (1hr) | TP 2 (2hr) | Day 2 (BW) |
|---|---|---|---|---|---|
| 1A00003M | A | 18.0 | 17.820 | 17.877 | 20.015 |
| 1A00004M | A | 19.0 | 18.430 | 18.533 | 17.520 |
| 1B00002F | A | 19.4 | 19.012 | 20.533 | 21.354 |
| 1B00001F | A | 18.4 | 18.032 | 17.852 | 18.744 |
| 2A00003M | B | 19.3 | 19.107 | 20.444 | 21.671 |
| 2A00001M | B | 18.9 | 19.467 | 20.635 | 20.016 |
| 2B00002F | B | 19.5 | 19.500 | 21.060 | 22.113 |
| 2B00004F | B | 18.5 | 19.055 | 20.008 | 20.808 |
| 3A00003M | C | 19.3 | 19.879 | 20.196 | 19.160 |
| 3A00004M | C | 19.0 | 18.700 | 20.078 | 21.282 |
| 3B00002F | C | 18.7 | 18.620 | 18.248 | 21.408 |
| 3B00001F | C | 19.0 | 19.760 | 20.550 | 20.756 |
| Observation Set | Timepoint | Subjects | Date Completed | StudyTask Rec |
|---|---|---|---|---|
| Baseline BW (Group 1+2+3) | Day 0 / 0h | 12 | Mar 10, 2026 18:30 | 517979, 517902, 517904 |
| Post-Dose Obs TP1 | +1h (3600 s) | 12 | Mar 10, 2026 18:31 | 517981 |
| Post-Dose Obs TP2 | +2h (7200 s) | 12 | Mar 10, 2026 18:31 | 517975 |
| Day 1 Dosing + BW | Day 1 | 8 | Mar 10, 2026 18:32 | 517976 |
| Day 1 Post-Dose +1h | Day 1 +1h | 12 | Mar 10, 2026 18:32 | 517980 |
| Day 1 Post-Dose +2h | Day 1 +2h | 12 | Mar 10, 2026 18:32 | 517974 |
| Day 2 Dosing + BW | Day 2 | 8 | Mar 10, 2026 18:33 | 517973 |
| Day 2 Post-Dose +1h | Day 2 +1h | 12 | Mar 10, 2026 18:33 | 517977 |
| Day 2 Post-Dose +2h | Day 2 +2h | 12 | Mar 10, 2026 18:34 | 517978 |